(JAMA and Archives Journals) An analysis of comparative effectiveness studies finds that few compare medications with nonpharmacologic interventions, and few examine safety or cost-effectiveness, according to a study in the March 10 issue of JAMA.
Read »Navigation
User login
Visit the BiotechMashup Blog